March 3, 2009
New innovation to help enable semiconductor and pharmaceutical industries to evaluate and influence vital ultra-small structures RESEARCH TRIANGLE PARK, N.C.--Just as x-ray technology, MRI and sonography transformed the practice of medicine, a newly created approach for seeing the invisible promises great potential for finding new ways to improve the health of human and microelectronic patients [...]
Agilent Technologies Introduces Next-Generation Microarrays, Quadrupling Probe Density
March 3, 2009
SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A - News) today announced the introduction of its SurePrint G3 Microarrays. These third-generation Agilent microarrays contain up to one million probes on a standard 1in. x 3 in. glass slide. Initial applications are array-based comparative genomic hybridization (aCGH) and copy number variation (CNV), with other applications to follow. Source: [...]
Akron Biotechnology Merging with AppliChem, a Leading BioChemicals Manufacturer
March 3, 2009
BOCA RATON, Fla.--Akron Biotechnology, LLC is pleased to announce its highly anticipated merger with the leading manufacturer of chemicals and biochemicals, AppliChem, GmbH. AppliChem, located in Darmstadt Germany, and Akron Biotech, located in Boca Raton FL, USA are merging forces for the manufacturing and distribution of both companies’ products. Commencing on March 2nd, 2009, Akron [...]
March 2, 2009
AARHUS, Denmark--The Einstein Center for Epigenomics at the Albert Einstein College of Medicine in Bronx, New York, has entered into an agreement with CLC bio to put the company's full suite of bioinformatics tools into the hands of epigenomics researchers and other investigators at the College. The suite includes CLC bio’s premier solutions for handling [...]
FlexGen Closes New Round of Financing
March 2, 2009
FlexGen, a Dutch Life Sciences company, is active in the genetic research market with a proprietary custom microarray synthesis instrument. The financing will allow FlexGen to speed up the development and global commercialization of its FlexArrayer, an instrument that provides researchers with unprecedented freedom in the production of custom microarrays. FlexGen is collaborating with several [...]
Veeco Introduces the BioScope Catalyst Life Science AFM
March 2, 2009
The New Standard in AFM and Light Microscopy Integration PLAINVIEW, N.Y.--Veeco Instruments Inc. (Nasdaq: VECO - News), a leading provider of instrumentation to the nanoscience community, announced today the release of its BioScope™ Catalyst™ Life Science Atomic Force Microscope (AFM). The Catalyst provides an unprecedented level of integration between atomic force microscopy and light microscopy. [...]
Wyeth Purchases Fujifilm AP-3000 Label-Free SPR System for Screening Chemical Fragments
March 2, 2009
STAMFORD, Conn.--FUJIFILM Corporation announced that Wyeth (NYSE: WYE) has purchased an AP-3000 label-free surface plasmon resonance (SPR) detection system. The AP-3000 will support Wyeth’s medicinal chemistry department in screening small chemical fragments during drug discovery. Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. Using a proprietary, high-sensitivity SPR biosensor, [...]
IU and Prosolia Partner on Life Science Project
March 2, 2009
NIH Small Business Grant to Stimulate Technological Innovation INDIANAPOLIS, March 2, 2009. Prosolia, Inc. was awarded a Small Business Technology Transfer (STTR) grant by the National Institute of Health (NIH) for the development of a new ionization source in collaboration with Indiana University Bloomington. Funded by the National Center for Research Resources (NCRR), part of [...]
March 2, 2009
PALO ALTO, Calif. & LONDON--StemCells, Inc. (NASDAQ:STEM) and Stem Cell Sciences plc (AIM:STEM) (ASX:STC) announced today that they have entered into a definitive agreement pursuant to which StemCells will acquire the operating subsidiaries and certain related assets of Stem Cell Sciences (SCS) for 2,650,000 shares of StemCells common stock and approximately $715,000 in cash. Stem [...]
Gen-Probe Borrows $170 Million Under New Line of Credit
March 2, 2009
SAN DIEGO, Calif., March 2 -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that it is borrowing $170 million under a newly issued line of credit to finance its pending acquisition of Tepnel Life Sciences PLC and other general corporate activities, including its existing share repurchase program. The Company will pay interest on the one-year, $180 [...]
